The content on this site is intended for healthcare professionals only
Dr Ana Botero speaks to ecancer at the 2019 ASCO Direct Highlights Symposium in Miami about the radiation oncology highlights from this year's meeting.
She begins by describing the NSABP-39 study, which looked at the effects of partial breast radiation therapy compared to whole breast radiation therapy in patients with early-stage breast cancer.
Dr Botero also discusses another study which compared transoral robotic surgery (TORS) to combined chemoradiation therapy in patients with squamous cell carcinoma.
Moving onto locally advanced lung cancer, she also describes a study which evaluated the incorporation of checkpoint inhibitors with chemoradiation therapy - which so far is displaying some benefit in the local control of the disease.
Lastly, Dr Botero discusses the use of whole-brain radiation and stereotaxic radiation therapy to treat brain metastases.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
The advantages of IORT for early breast cancer treatment
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
